NewEdge Advisors’s Oscar Health OSCR Stock Holding History

NewEdge Advisors’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.69M	Sell	94,411 -10,744	-10%	-$231K	0.01%	1063
2026 Q1	$1.21M	Sell	105,155 -4,759	-4%	-$67K	﹤0.01%	1388
2025 Q4	$1.58M	Sell	109,914 -109,196	-50%	-$1.89M	0.01%	1193
2025 Q3	$4.15M	Buy	219,110 +34,737	+19%	+$572K	0.02%	706
2025 Q2	$3.95M	Sell	184,373 -3,685	-2%	-$54.8K	0.02%	654
2025 Q1	$2.47M	Buy	188,058 +88,946	+90%	+$1.32M	0.01%	766
2024 Q4	$1.33M	Buy	99,112 +98,112	+9,811%	+$1.58M	0.01%	1018
2024 Q3	$21.2K	Hold	1,000	–	–	﹤0.01%	2700
2024 Q2	$15.8K	Buy	+1,000	New	+$18.4K	﹤0.01%	2701
2024 Q1	–	Sell	-2	Closed	-$18	–	3929
2023 Q4	$18	Hold	2	–	–	﹤0.01%	3701
2023 Q3	$11	Hold	2	–	–	﹤0.01%	3438
2023 Q2	$16	Hold	2	–	–	﹤0.01%	3459
2023 Q1	$13	Hold	2	–	–	﹤0.01%	3392
2022 Q4	$0	Buy	+2	New	+$6	﹤0.01%	4171

Other funds holding OSCR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NewEdge Advisors's OSCR Position: Q2 2026 in Review

NewEdge Advisors reduced its Oscar Health (OSCR) stake by 10% in Q2 2026, selling an estimated $231K and leaving 94,411 shares worth $2.69M. The position accounts for 0.01% of the portfolio, ranked #1063.

NewEdge Advisors first reported a position in OSCR in Q4 2022 and has held it in 14 quarters since. The position peaked at $4.15M in Q3 2025. 403 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

NewEdge Advisors held 94,411 shares of Oscar Health worth $2.69M as of Q2 2026.
NewEdge Advisors sold 10,744 Oscar Health shares in Q2 2026, an estimated $231K.
Oscar Health made up 0.01% of NewEdge Advisors's portfolio in Q2 2026, its #1063 holding.
NewEdge Advisors first reported a position in Oscar Health in Q4 2022 and has held it in 14 quarters since.
NewEdge Advisors's Oscar Health position peaked at $4.15M in Q3 2025.
403 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.